<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">34111831</PMID><DateCompleted><Year>2021</Year><Month>10</Month><Day>11</Day></DateCompleted><DateRevised><Year>2024</Year><Month>09</Month><Day>08</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1873-1244</ISSN><JournalIssue CitedMedium="Internet"><Volume>90</Volume><PubDate><Year>2021</Year><Month>Oct</Month></PubDate></JournalIssue><Title>Nutrition (Burbank, Los Angeles County, Calif.)</Title><ISOAbbreviation>Nutrition</ISOAbbreviation></Journal><ArticleTitle>Altered tryptophan absorption and metabolism could underlie long-term symptoms in survivors of coronavirus disease 2019 (COVID-19).</ArticleTitle><Pagination><StartPage>111308</StartPage><MedlinePgn>111308</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.nut.2021.111308</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0899-9007(21)00170-2</ELocationID><Abstract><AbstractText>The global pandemic of COVID-19 has been lasting for more than one year and there is little known about the long-term health effects of the disease. Long-COVID is a new term that is used to describe the enduring symptoms of COVID-19 survivors. Huang et&#xa0;al. reported that fatigue, muscle weakness, sleep disturbances, anxiety, and depression were the most common complaints in COVID-19 survivors after 6 months of the infection. A recent meta-analysis showed that 80% of COVID-19 survivors have developed at least one long-term symptom and the most common five were fatigue, headache, attention deficit disorder, hair loss, and dyspnea. In this paper, we discuss the hypothesis that altered tryptophan absorption and metabolism could be the main contributor to the long-term symptoms in COVID-19 survivors.</AbstractText><CopyrightInformation>Copyright &#xa9; 2021 Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Ero&#x11f;lu</LastName><ForeName>&#x130;mdat</ForeName><Initials>&#x130;</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, Faculty of Medicine, Hacettepe University, Ankara, Turkey. Electronic address: i.eroglu.1903@gmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ero&#x11f;lu</LastName><ForeName>Burcu &#xc7;elik</ForeName><Initials>B&#xc7;</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, Faculty of Medicine, Hacettepe University, Ankara, Turkey.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>G&#xfc;ven</LastName><ForeName>G&#xfc;lay Sain</ForeName><Initials>GS</Initials><AffiliationInfo><Affiliation>Department of General Internal Medicine, Faculty of Medicine, Hacettepe University, Ankara, Turkey.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>05</Month><Day>01</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Nutrition</MedlineTA><NlmUniqueID>8802712</NlmUniqueID><ISSNLinking>0899-9007</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>8DUH1N11BX</RegistryNumber><NameOfSubstance UI="D014364">Tryptophan</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017741" MajorTopicYN="N">Survivors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014364" MajorTopicYN="N">Tryptophan</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Altered</Keyword><Keyword MajorTopicYN="N">Covid-19</Keyword><Keyword MajorTopicYN="N">Long-covid</Keyword><Keyword MajorTopicYN="N">Malabsorption</Keyword><Keyword MajorTopicYN="N">Metabolism</Keyword><Keyword MajorTopicYN="N">Tryptophan</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>2</Month><Day>4</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2021</Year><Month>4</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>4</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>6</Month><Day>11</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>10</Month><Day>12</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>6</Month><Day>10</Day><Hour>20</Hour><Minute>24</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2021</Year><Month>5</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34111831</ArticleId><ArticleId IdType="pmc">PMC8087860</ArticleId><ArticleId IdType="doi">10.1016/j.nut.2021.111308</ArticleId><ArticleId IdType="pii">S0899-9007(21)00170-2</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Sudre CH, Murray B, Varsavsky T, Graham MS, Penfold RS, Bowyer RC, et al. Attributes and predictors of long COVID. Nat Med. 2021;NN:1&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7611399</ArticleId><ArticleId IdType="pubmed">33692530</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang C, Huang L, Wang Y, Li X, Ren L, Gu X, et al. 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study. Lancet. 2021 NN:PPP&#x2013;PPP.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7833295</ArticleId><ArticleId IdType="pubmed">33428867</ArticleId></ArticleIdList></Reference><Reference><Citation>Lopez-Leon S, Wegman-Ostrosky T, Perelman C, Sepulveda R, Rebolledo PA, Cuapio A, et al. More than 50 long-term effects of COVID-19: a systematic review and meta-analysis. Preprint. medRxiv. 2021;2021.01.27.21250617. Published 2021 Jan 30. doi:10.1101/2021.01.27.21250617</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8352980</ArticleId><ArticleId IdType="pubmed">34373540</ArticleId></ArticleIdList></Reference><Reference><Citation>Platten M, Nollen EAA, R&#xf6;hrig UF, Fallarino F, Opitz CA. Tryptophan metabolism as a common therapeutic target in cancer, neurodegeneration and beyond. Nat Rev Drug Discov. 2019;18:379&#x2013;401.</Citation><ArticleIdList><ArticleId IdType="pubmed">30760888</ArticleId></ArticleIdList></Reference><Reference><Citation>Cervenka I, Agudelo LZ, Ruas JL. Kynurenines: tryptophan's metabolites in exercise, inflammation, and mental health. Science. 2017;357:PPP&#x2013;PPP.</Citation><ArticleIdList><ArticleId IdType="pubmed">28751584</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen Y, Guillemin GJ. Kynurenine pathway metabolites in humans: disease and healthy states. Int J Tryptophan Res. 2009;NN:PPP&#x2013;PPP.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3195227</ArticleId><ArticleId IdType="pubmed">22084578</ArticleId></ArticleIdList></Reference><Reference><Citation>Boergeling Y, Ludwig S. Targeting a metabolic pathway to fight the flu. FEBS J. 2017;284:218&#x2013;221.</Citation><ArticleIdList><ArticleId IdType="pubmed">28121076</ArticleId></ArticleIdList></Reference><Reference><Citation>Hwang SL, Nancy Chung NP-Y, Chan JK-Y, Lin C-L S. Indoleamine 2, 3-dioxygenase (IDO) is essential for dendritic cell activation and chemotactic responsiveness to chemokines. Cell Res. 2005;15:167&#x2013;175.</Citation><ArticleIdList><ArticleId IdType="pubmed">15780178</ArticleId></ArticleIdList></Reference><Reference><Citation>Lionetto L, Ulivieri M, Capi M, Bernardini DD, Fazio F, Petrucca A, et al. Increased kynurenine-to-tryptophan ratio in the serum of patients infected with SARS-CoV2: an observational cohort study. Biochim Biophys Acta Mol Basis Dis. 2021;1867</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7834629</ArticleId><ArticleId IdType="pubmed">33338598</ArticleId></ArticleIdList></Reference><Reference><Citation>Munn DH, Mellor AL. Indoleamine 2, 3 dioxygenase and metabolic control of immune responses. Trends Immunol. 2013;34:137&#x2013;143.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3594632</ArticleId><ArticleId IdType="pubmed">23103127</ArticleId></ArticleIdList></Reference><Reference><Citation>Thomas T, Stefanoni D, Reisz JA, Nemkov T, Bertolone L, Francis RO, et al. COVID-19 infection alters kynurenine and fatty acid metabolism, correlating with IL-6 levels and renal status. JCI Insight. 2020;5 PPP&#x2013;PPP.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7453907</ArticleId><ArticleId IdType="pubmed">32559180</ArticleId></ArticleIdList></Reference><Reference><Citation>Barberis E, Timo S, Amede E, Vanella VV, Puricelli C, Cappellano G, et al. Large-scale plasma analysis revealed new mechanisms and molecules associated with the host response to SARS-CoV-2. Int J Mol Sci. 2020;21:8623.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7696386</ArticleId><ArticleId IdType="pubmed">33207699</ArticleId></ArticleIdList></Reference><Reference><Citation>Robertson J, Gostner JM, Nilsson S, Andersson L-M, Fuchs D, Gisslen M. Serum neopterin levels in relation to mild and severe COVID-19. BMC Infect Dis. 2020;20:1&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7726600</ArticleId><ArticleId IdType="pubmed">33302893</ArticleId></ArticleIdList></Reference><Reference><Citation>Mangoni A. The &#x201c;kynurenine shunt&#x201d; and depression. Adv Biochem Psychopharmacol. 1974;11(0):293-298.</Citation><ArticleIdList><ArticleId IdType="pubmed">4276862</ArticleId></ArticleIdList></Reference><Reference><Citation>R&#xe9;us GZ, Jansen K, Titus S, Carvalho AF, Gabbay V, Quevedo J. Kynurenine pathway dysfunction in the pathophysiology and treatment of depression: evidences from animal and human studies. J Psychiatr Res. 2015;68:316&#x2013;328.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4955923</ArticleId><ArticleId IdType="pubmed">26028548</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamashita M. Potential role of neuroactive tryptophan metabolites in central fatigue: establishment of the fatigue circuit. Int J Tryptophan Res. 2020;13</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7325545</ArticleId><ArticleId IdType="pubmed">32647476</ArticleId></ArticleIdList></Reference><Reference><Citation>N&#xe9;meth H, Toldi J, V&#xe9;csei L. Role of kynurenines in the central and peripherial nervous systems. Curr Neurovasc Res. 2005;2:249&#x2013;260.</Citation><ArticleIdList><ArticleId IdType="pubmed">16181118</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamamoto T, Azechi H, Board M. Essential role of excessive tryptophan and its neurometabolites in fatigue. Can J Neurol Sci. 2012;39:40&#x2013;47.</Citation><ArticleIdList><ArticleId IdType="pubmed">22384494</ArticleId></ArticleIdList></Reference><Reference><Citation>Carpenedo R, Pittaluga A, Cozzi A, Attucci S, Galli A, Raiteri M, Moroni F. Presynaptic kynurenate-sensitive receptors inhibit glutamate release. Eur J Neurosci. 2001;13:2141&#x2013;2147.</Citation><ArticleIdList><ArticleId IdType="pubmed">11422455</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu HQ, Pereira EF, Bruno JP, Pellicciari R, Albuquerque EX, Schwarcz R. The astrocyte-derived alpha7 nicotinic receptor antagonist kynurenic acid controls extracellular glutamate levels in the prefrontal cortex. J Mol Neurosci. 2010;40(1-2):204&#x2013;210.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3929341</ArticleId><ArticleId IdType="pubmed">19690987</ArticleId></ArticleIdList></Reference><Reference><Citation>Viana SD, Nunes S, Reis F. ACE2 imbalance as a key player for the poor outcomes in COVID-19 patients with age-related comorbidities&#x2014;role of gut microbiota dysbiosis. Ageing Res Rev. 2020 NN.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7365123</ArticleId><ArticleId IdType="pubmed">32683039</ArticleId></ArticleIdList></Reference><Reference><Citation>Perlot T, Penninger JM. ACE2&#x2014;from the renin&#x2013;angiotensin system to gut microbiota and malnutrition. Microbes Infect. 2013;15:866&#x2013;873.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7110844</ArticleId><ArticleId IdType="pubmed">23962453</ArticleId></ArticleIdList></Reference><Reference><Citation>Klempin F, Valentina Mosienko V, Matthes S, Villela DC, Todiras M, Penninger JM, et al. Depletion of angiotensin-converting enzyme 2 reduces brain serotonin and impairs the running-induced neurogenic response. Cell Mol Life Sci. 2018;75:3625&#x2013;3634.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7079801</ArticleId><ArticleId IdType="pubmed">29679094</ArticleId></ArticleIdList></Reference><Reference><Citation>Lieben C, Blokland A, Westerink B, Deutz nep. Acute tryptophan and serotonin depletion using an optimized tryptophan-free protein&#x2013;carbohydrate mixture in the adult rat. Neurochem Int. 2004;44:9&#x2013;16.</Citation><ArticleIdList><ArticleId IdType="pubmed">12963083</ArticleId></ArticleIdList></Reference><Reference><Citation>Nishizawa S, Benkelfat C, Young SN, Leyton M, Mzengeza S, de Montigny C, et al. Differences between males and females in rates of serotonin synthesis in human brain. Proc Natl Acad Sci U S A. 1997;94(10):5308&#x2013;5313.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC24674</ArticleId><ArticleId IdType="pubmed">9144233</ArticleId></ArticleIdList></Reference><Reference><Citation>Jenkins TA, Nguyen JCD, Polglaze KE, Bertrand PP. Influence of tryptophan and serotonin on mood and cognition with a possible role of the gut-brain axis. Nutrients. 2016;8:56.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4728667</ArticleId><ArticleId IdType="pubmed">26805875</ArticleId></ArticleIdList></Reference><Reference><Citation>Bhatti T, Gillin JC, Seifritz E, Moore P, Clark C, Golshan S, Stahl S, et al. Effects of a tryptophan-free amino acid drink challenge on normal human sleep electroencephalogram and mood. Biol Psychiatry. 1998;43:52&#x2013;59.</Citation><ArticleIdList><ArticleId IdType="pubmed">9442344</ArticleId></ArticleIdList></Reference><Reference><Citation>Essa MM, Hamdan H, Chidambaram SB, Al-Balushi B, Guillemin GJ, Ojcius DM, et al. Sage UK; London: 2020. Possible role of tryptophan and melatonin in COVID-19.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7443751</ArticleId><ArticleId IdType="pubmed">32913393</ArticleId></ArticleIdList></Reference><Reference><Citation>Ninomiya S, Nakamura N, Nakamura H, Mizutani T, Kaneda Y, Yamaguchi K, et al. Low levels of serum tryptophan underlie skeletal muscle atrophy. Nutrients. 2020;12:978.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7230402</ArticleId><ArticleId IdType="pubmed">32244785</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>